权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling

减肥手术后 NAFLD 的改善：胆汁酸信号传导的作用

基本信息

批准号：
9244018
负责人：
Rohit Kohli
金额：
$ 48.21万
依托单位：
CHILDREN'S HOSPITAL OF LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-04-01 至 2020-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9244018
关键词：
Abdomen Acids Adolescent Adolescent obesity Adult Adverse effects Affect Agonist Alpha Cell Bariatrics Bile Acids Bile fluid Body Weight decreased Calories Cell Culture Techniques Cells Cirrhosis Clinical Trials Comorbidity Data Development Eating Elements Enterocytes FGF19 gene FGFR4 gene Fatty Liver Fatty acid glycerol esters Fibroblast Growth Factor Funding Gastrectomy Gastric Bypass Genes Goals Hepatic Hepatocyte Histologic Human Hyperlipidemia In Vitro Injury Intake Intestines Link Lipids Liver Liver diseases Malabsorption Syndromes Mediating Messenger RNA Metabolic Molecular Morbid Obesity Mus Nature Nuclear Receptors Obesity Obesity associated liver disease Operative Surgical Procedures Orthologous Gene Outcome Pancreas Phase III Clinical Trials Play Populations at Risk Procedures Proteins Rattus Reporting Resolution Risk Rodent Role Serum Signal Pathway Signal Transduction Site Small Interfering RNA Stomach System Technology Testing Tissues Triglycerides United States United States National Institutes of Health Weight Work bariatric surgery base cost food restriction glucose production ileum improved in vivo lifestyle intervention liver transplantation mimetics mouse model non-alcoholic fatty liver nonalcoholic steatohepatitis novel public health relevance receptor relating to nervous system success

项目摘要

DESCRIPTION (provided by applicant): Bariatric surgery remains the most effective and durable treatment option for obesity to date. More importantly, beyond weight loss, bariatric procedures have many advantageous metabolic effects including resolution of advanced obesity related liver disease or nonalcoholic steatohepatitis (NASH). Steatosis (fat in liver cells) is the defining element of NASH and a precursor to the development of cirrhosis and the potential need for liver transplantation. In particular, we have studied the potent impact of a bariatric procedure termed Vertical Sleeve Gastrectomy (VSG) on resolution of NASH. Simultaneously we have observed increased serum bile acids and downstream bile acid signaling in mice that undergo VSG surgery. Importantly, these effects are not simply the result of weight loss since our data show that the resolution of NASH and increase in serum bile acids are not seen in rodents that lose an equivalent amount of weight via food restriction. These studies build on our prior work wherein we have studied other bariatric procedures and their effects on bile acid driven signaling. These have included experimental procedures such as "ileal transposition" or bile diversion and established procedures such as roux-en Y gastric bypass and the adjustable gastric band. In this proposal Dr. Kohli will focus on the mechanisms of NASH resolution after VSG surgery using an obese murine model. The specific aims of his proposal will examine the effect of a specific bile acid triggered intestinal signal, fibroblast growth factor 15/19 (Fgf15/1). In inter-related aims Dr. Kohli proposes to study the mechanism of (Aim 1) intestinal; and (Aim 2) liver Fgf15/19 signaling. Each of these aims has studies that span from cell culture based approaches to dissect the signaling pathways, mice VSG surgery, and translational human studies to validate our findings.